Details for Patent: 7,608,282

Which drugs does patent 7,608,282 protect, and when does it expire?

Patent 7,608,282 protects SANCUSO and is included in one NDA.

This patent has forty patent family members in thirty-one countries.

Summary for Patent: 7,608,282

Title:	Transdermal granisetron
Abstract:	Adhesive patches for the transdermal administration of granisetron, comprise an acrylic adhesive containing non-acidic nucleophilic moieties which substantially increase flux of granisetron across the skin.
Inventor(s):	Altenschopfer; Peter (Ortenburg, DE), Watkinson; Adam Charles (Victoria, AU)
Assignee:	Strakan International Limited (Hamilton, BM)
Application Number:	10/544,259
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,608,282
Patent Claim Types: see list of patent claims	Compound; Use;

Drugs Protected by US Patent 7,608,282

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Cumberland	SANCUSO	granisetron	FILM, EXTENDED RELEASE;TRANSDERMAL	022198-001	Sep 12, 2008		RX	Yes	Yes			Y			USE OF GRANISETRON TRANSDERMAL SYSTEM TO TREAT/PREVENT CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

Foreign Priority and PCT Information for Patent: 7,608,282

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0302662.2	Feb 05, 2003

PCT Information
PCT Filed	February 05, 2004	PCT Application Number:	PCT/GB2004/000403
PCT Publication Date:	August 19, 2004	PCT Publication Number:	WO2004/069141

International Family Members for US Patent 7,608,282

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	368454
Australia	2004210181
Brazil	PI0407280
Canada	2515094